Your browser doesn't support javascript.
loading
Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals.
Seidel, Danila; Simon, Michaela; Sprute, Rosanne; Lubnow, Matthias; Evert, Katja; Speer, Claudius; Seeßle, Jessica; Khatamzas, Elham; Merle, Uta; Behrens, Christopher; Blau, Igor Wolfgang; Enghard, Philipp; Haas, Christian S; Steinmann, Joerg; Kurzai, Oliver; Cornely, Oliver A.
Afiliação
  • Seidel D; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Simon M; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Sprute R; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Lubnow M; Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.
  • Evert K; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Speer C; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Seeßle J; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Khatamzas E; Department of Anesthesiology and Intensive Care, University Hospital Regensburg, Regensburg, Germany.
  • Merle U; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Behrens C; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Blau IW; Department of Gastroenterology and Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Enghard P; Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Haas CS; Department of Gastroenterology and Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Steinmann J; Department Medizinische Mikrobiologie und Technische Hygiene, Medizet, Städtisches Klinikum München GmbH, Munich, Germany.
  • Kurzai O; Department of Hematology, Oncology and Cancer Immunology, Charité University Medicine Berlin, Berlin, Germany.
  • Cornely OA; Department of Nephrology and Medical Intensive Care, Charité University Medicine Berlin, Berlin, Germany.
Mycoses ; 65(1): 103-109, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34655486
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Mucormicose Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Mycoses Assunto da revista: MICROBIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Mucormicose Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Mycoses Assunto da revista: MICROBIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha